MS, Senior Director, Biobank & Translational Research Core and Research Support Services, Department of Surgery, Duke University
Jennifer Cheeseman is the Senior Director of BioDuke, the new biobanking initiative within the Duke University, School of Medicine. She is responsible for overseeing the strategic development of the centralized biobanking initiative while implementing a physical infrastructure that aligns existing resources to leverage economies of scale for optimization and standardization for biospecimen collection, processing, storage, distribution, quality control, and clinical data collection and linkage. Jennifer has spent the last 3 years at Duke University developing research support via core services, improving and developing core infrastructure, improving long term strategic planning and promotion of collaborative and transformative research with collaborators both internally and externally. She serves as the biobanking lead of two Department of Defense biobanking consortiums in collaboration with Duke University, Department of Surgery, the Surgical Critical Care Initiative (SC2i) supporting precision medicine in wounded warriors and the Vascular Composite Allograft Collaborative Initiative (VCAci) supporting translational research in hand transplantation. Prior to joining Duke Jennifer served as the Director of the Emory University Transplant Center Biorepository where she developed and implemented an Integrated Research Support Service that encompassed study development around sample and clinical data collection and linking, financial planning, project management, clinical regulatory and institutional compliance, improving on organizational efficiency within the academic setting at both divisional and departmental levels. Jennifer earned her BS and MS from the University of Florida and is currently completing her MBA at North Carolina State University.
Session Synopsis: The demand for high quality biosamples poses a unique challenge to the advancement of Precision -omics based research. This session will evaluate the complexities involved in managing longitudinal studies with an emphasis on biosample quality, logistics, kit management, site training, sample management, consent management, and data management. When done well, large longitudinal Cohort Studies stand to provide an increasingly significant portion of the supply to support the increase in -omics based research